European Shortages Monitoring Platform (ESMP) open Application Programming Interface (API) specifications for the ESMP API for marketing authorisation holders (MAHs) (JSON) (YAML)
Join Our Upcoming Webinar!
Title: "Hospitalist Model and Co-Management in Surgical Areas Across Europe" organised by EFIM Multimorbidity WG.
Date: Tuesday, 29th April
Time: 17:30 – 18:30 CET
Guidance for Rapporteurs and members of drafting groups of documents developed by the GMP/GDP Inspectors Working Group
Three year work plan for the Good Manufacturing Practice / Good Distribution Practice Inspectors Working Group 2025-2027
Annual report of the Good Manufacturing and Distribution Practice Inspectors Working Group 2024
Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 40, Status: Authorised
Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab emtansine, Date of authorisation: 15/11/2013, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 21, Status: Authorised
EMEA-003589-PIP01-24